Stock market analysts watching La Jolla Pharmaceutical Company (LJPC) have recently changed their ratings on the stock. The latest reports which are outstanding on Monday 14th of August state 1 analyst has a rating of “strong buy”, …
The stock is now traded at around $11.92. The impact to the portfolio due to this purchase was 0.8%. The holdings were 250,000 shares as of 2017-06-30. Added: La Jolla Pharmaceutical Co (LJPC) Boxer Capital, LLC added to the holdings …
Drug Trial Results Weigh on LJPC Stock Mixed drug trial results for its experimental blood pressure drug has shares of La Jolla Pharmaceutical down 3.4% today at $32.86. Earlier in the session, LJPC stock fell as low as $29.51. An analyst …
LJPC) traded up 2.24% during trading on Friday, reaching $31.48. The company’s stock had a trading volume of 121,776 shares. The stock’s market cap is $696.43 million. The company’s 50-day moving average is $30.87 and its 200-day …
Is GoPro Stock A Good Turnaround Play? La Jolla Pharmaceutical (LJPC) Jumps: Stock Gains 12.3% - Tale of the Tape Can The Uptrend Continue for La Jolla Pharmaceutical (LJPC)? - Tale of the Tape La Jolla Pharmaceutical (LJPC) in …
Investors in La Jolla Pharmaceutical Company (LJPC - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 16th, 2017 $20 Put had some of the highest implied …
ZACKS2mon
La Jolla Pharmaceutical (LJPC) stock launched to a 17-month high Monday after its hypotension drug showed extreme efficacy in a phase 3 trial, cutting mortality risk by nearly a quarter after 28 days. On the stock market today, La Jolla …
La Jolla Pharmaceutical Company (NASDAQ:LJPC)‘s stock had its “buy” rating restated by analysts at Jefferies Group LLC in a research note issued to investors on Tuesday. They presently have a $40.00 price target on the …